Wednesday, February 19, 2025 The European Society for Medical Oncology (ESMO) has announced that the recipient of the 2025 TAT Honorary Award is Philippe Bedard, Professor of Medicine at the University of Toronto, Staff Medical Oncologist in the Division of Medical Oncology, Director of the Cancer Genomics Program, and a Principal Investigator in the Bras Drug Development Program at the Princess Margaret Cancer Centre, in Toronto, Canada.Dr. Bedard has been a valued CCTG investigator and collaborator for many years and is the past Chair of the CCTG IND committee and current chair of the IND Early Trials Advisory Group. His clinical practice includes the treatment of patients with breast and testicular cancers. His research program involves early phase clinical trials with novel cancer drug treatments. These emerging treatments include immunotherapy and the personalization of cancer treatment based upon the results of testing for DNA mutations within tumor cells. Dr Bedard will deliver the Award lecture “Bridging cancer genomics and drug development: An academic perspective" on Monday, 3 March at the ESMO TAT Congress 2025 in Paris, France.
